Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: The involvement of the serotonergic system

Behavioural Brain Research

Volumn 92, Issue 2, 1998, Pages 111-118

  Waldinger, Marcel D ^a,d   Berendsen, Hemmie H G ^b   Blok, Bertil F M ^c   Olivier, Berend ^d   Holstege, Gert ^c  

^a LEYENBURG HOSPITAL   (Netherlands)

^b NV ORGANON   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Premature ejaculation; Serotonergic antidepressants; Sexual dysfunction

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; QUIPAZINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CLINICAL TRIAL; HUMAN; NERVE PROJECTION; NEUROANATOMY; NEUROPHYSIOLOGY; NONHUMAN; PREMATURE EJACULATION; PRIORITY JOURNAL; RAPHE NUCLEUS; SEROTONINERGIC SYSTEM;

ANIMALS; EJACULATION; HUMANS; MALE; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 0032079904     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00183-6     Document Type: Article

References (58)

1. [1] Abraham K. Uber ejaculatio praecox, Zeitschr. f. ärztl. Psychoanalyse 1917;IV:171-86.
2. [2] Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wilkstrom H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 1981;15:785-92.
3. [3] Althof SE, Levine SB, Corty EW, Risen CB, Stern EB, Kurit DM. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995;56:402-7.
4. [4] American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Washington, DC: American Psychiatric Association, 1994.
5. [5] Aycock L. The medical management of premature ejaculation. J Urol 1949;62:361-2.
6. [6] Bennett D. Treatment of ejaculatio praecox with monoamine-oxidase inhibitors (letter). Lancet 1961;II:1309.
7. [7] Benson G. Male sexual function: erection, emission and ejaculation. In: Knobil E, Neill JD, editors. The Physiology of Reproduction. New York: Raven Press, 1988.
8. [8] Berendsen HHG, Broekkamp CLE. Drug-induced penile erections in rats: indications of serotonin 1B receptor mediation. Eur J Pharmacol 1987;338:191-5.
9. [9] Berendsen HHG, Broekkamp CLE. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol 1990;101:667-73.
10. [10] Berendsen HHG, Broekkamp CLE. Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure. Eur J Pharmacol 1994;253:83-9.
11. 1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav 1989;33:821-7.
12. 1c-receptors in drug-induced penile erections in rats. Psychopharmacology 1990;101:57-61.
13. [13] Berkovitch M, Keresteci AG, Koren G. Efficacy of prilocainelidocaine cream in the treatment of premature ejaculation. J Urol 1995;154:1360-1.
14. [14] Bertacinni G, Chieppa S. Urinary excretion of 5-hydroxyindoleacetic acid after removal of the large intestine in man. Lancet 1960;1:881.
15. [15] Crenshaw R, Prozac and Premature Ejaculation, Annual Meeting of the American Association of Sex Educators, Counselors and Therapists, Orlando, FL, 1992.
16. [16] Damrau F. Premature ejaculation: use of ethyl aminobenzoate to prolong coitus. J Urol 1963;89:936-9.
17. [17] DeAmicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sexual Behav 1985;14:467-89.
18. [18] de Groat WC, Steers WD. Autonomic regulation of the urinary bladder and sexual organs. In: Loewy AD, Spyer KM, editors. Central Regulation of Autonomic Functions. Oxford: Oxford University Press, 1990:310-33.
19. [19] Erspamer V. Asero, Identification of enteramin, the specific hormone of the enterochromaffin cell system. Nature 1952;169:800-1.
20. [20] Erspamer V. Pharmakologische studien uber enteramin; einige Eigenschaften des enteramins, sowie uber die abgrenzung des enteramins von den anderen kreislauf wirksamen gewebsprodukten. Arch f Exp Path Pharmacol 1940;196:336-90.
21. [21] Farthing MJG. 5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists. Scand J Gastroenterol 1991;26:92-100.
22. 2 receptor in the regulation of sexual performance of male rats. Life Sci 1989;45:1263-70.
23. [23] Girgis SM, El-Haggen S, El-Hermouzy SA. A double-blind trial of clomipramine in premature ejaculation. Andrologia 1982;29:364-8.
24. [24] Goodman RE. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res 1980;8(S3):53-9.
25. [25] Grahame-Smith DG. Serotonin (5-hydroxytryptamine, 5-HT). Q J Med 1988;67:459-66.
26. [26] Haensel SM, Rowland DL, Kallan KTHK, Slob AK. Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996;156:1310-5.
27. [27] Hawton K, Catalan J, Martin P, Fagg J. Long-term outcome of sex therapy. Behav Res Ther 1986;24:665-75.
28. [28] Holstege G. Descending motor pathways and the spinal motor system: limbic and non-limbic components. Progr Brain Res 1991;87:307-412.
29. [29] Holstege JC. The ventro-medial medullary projections to spinal motoneurons: ultrastructure, transmitters and functional aspects. In: Holstege G, Bandler R, Saper C, editors. The Emotional Motor System. Progr Brain Res, vol. 107. Amsterdam: Elsevier, 1996:159-82.
30. [30] Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin EJ, Mylecharane PR, Saxena PR, Humphrey PPA. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46:157.
31. [31] Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229.
32. [32] Marberger H. The mechanisms of ejaculation. In: Coutinho EM, Fuchs F, editors. Physiology and Genetics of Reproduction; Basic Life Sciences, vol. 4. New York: Plenum Press, 1974.
33. [33] Masters WH, Johnson VE. Premature ejaculation. In: Masters WH, Johnson VE, editors. Human Sexual Inadequacy. Boston, MA: Little, Brown and Co., 1970:92-115.
34. [34] Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995;15:341-6.
35. [35] Meston CM, Gorzalka BB. Psychoactive drugs and human sexual behavior: The role of serotonergic activity. J Psychoactive Drugs 1992;24:1-40.
36. [36] Molewijk HE, van der Heyden JAM, Olivier B. Lower lip retraction is selectively mediated by activation of the 5-HT1A receptor. Eur J Neurosci 1989;214(2):121-36.
37. [37] Molliver ME, Berger UV, Mamounas LA, Molliver DC, O'Hearn E, Wilson MA. Neurotoxicity of MDMA and related compounds: anatomical studies. Ann NY Acad Sci 1990;600:640-64.
38. 3H]spiroperidol. Mol Pharmacol 1979;16:687-99.
39. [39] Rapport MM. Serum vasoconstrictor (serotonin) V. Presence of creatinine in the complex. A proposed structure of the vasoconstrictor principle. J Biol Chem 1949;180:961-9.
40. [40] Relief PJM. Physiology of micturition and ejaculation. S Afr Med J 1950;24:509.
41. [41] Ruff GA, St. Lawrence JS. Premature ejaculation: past research progress, future directions. Clin Psychol Rev 1985;5:627-39.
42. [42] Segraves RT. Treatment of premature ejaculation with Lorazepam. Am J Psychiatry 1987;144:1240.
43. [43] Segraves RT, Saran A, Segraves K, Maguire E. Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther 1993;19:198-200.
44. [44] Semans JH. Premature ejaculation: a new approach. S Afr Med J 1956;49:353.
45. [45] Semans JH, Langworthy OR. Observations on the neorophysiology of sexual function in the male cat. J Urol 1938;40:836.
46. [46] Singer C, Weiner WJ. Male sexual response cycle. In: Singer CS, Weiner WJ, editors. Sexual Dysfunction, a Neuro-Medical Approach. Armonk: Futura, 1994:30-1.
47. [47] St. Lawrence JS, Madakasira S. Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatry Med 1992;22:77-97.
48. [48] Steinbush HWM. Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 1981;4:557-618.
49. [49] Szele FG, Murphy DL, Garrick NA. Effects of fenfluramine, m-chlorophenylpiperazine and other serotonin-related agonists and antagonists on penile erections in non-human primates. Life Sci 1988;43:1297-303.
50. [50] Tork I. Anatomy of the serotonergic system. Ann NY Acad Sci 1990;600:6-35.
51. [51] Twarag BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Physiol 1953;174:157-61.
52. [52] Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994;151: 1377-9.
53. [53] Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. An empirical operationalization study of the DSM-IV Diagnostic Criteria for Premature Ejaculation, 1997 (submitted).
54. [54] Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol 1997;79:592-5.
55. [55] Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. The effect of SSRI antidepressants on ejaculation: a double-blind, randomised, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1997 (in press).
56. [56] Waldinger MD, Rietschel M, Nothen NM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1997 (in press).
57. [57] Woolley DW, Shaw E. A biochemical and pharmacological suggestion about certain mental-disorders. Proc Natl Acad Sci 1954;40:228-31.
58. [58] Yap CY, Taylor DA. Involvement of 5-HT2 receptors in the wetdog shake behaviour induced by 5-hydroxytryptophan in the rat. Neuropharmacology 1983;22:801-4.